Phase I study of transcutaneous adjuvant in healthy volunteers

Phase I study of transcutaneous adjuvant in healthy volunteers - Phase I study of transcutaneous adjuvant

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018146

Enrollment

Registered

2015-07-01

Start date

2015-07-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy Others

Interventions

Band-aid with test drug is adhered on the arm for 6h. After detach the band-aid, local skin reaction and systematic adverse events are evaluated.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: The subjects must satisfy the following conditions. 1) Healthy male at the age of 20 to 65. 2) Subject who provides the written consent.

Exclusion criteria

Exclusion criteria: The following subjects must be excluded: 1) Subjects under any medical treatment or with diseases requiring medical treatment. 2) Subjects with the past history of severe diseases (diabetes, liver disease, kidney disease, heart disease). 3) Subject with the past history of severe allergic reactions, such as atopic dermatitis, except for those with weak reactions. 4) Subjects with hypersensitivity to adhesive tape. 5)Subject who are judged inappropriate for the trial enrollment based on the results of prior laboratory tests. 6) Subjects who are judged inappropriate for the clinical trial by doctors.

Design outcomes

Primary

Measure	Time frame
Safety	—

Countries

Japan

Contacts

Public ContactAkira Yamada

Kurume University Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy

akiymd@med.kurume-u.ac.jp0942-31-7744

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026